vs
Assertio Holdings, Inc.（ASRT）与enCore Energy Corp.（EU）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是enCore Energy Corp.的1.1倍（$13.5M vs $12.4M）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
德文能源是一家美国 hydrocarbon 勘探企业，公司注册于特拉华州，运营总部位于俄克拉荷马州俄克拉荷马城的德文能源中心，业务区块主要集中在特拉华盆地、伊格尔福特区块以及落基山脉区域，是美国本土重要的能源勘探开发企业。
ASRT vs EU — 直观对比
营收规模更大
ASRT
是对方的1.1倍
$12.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $12.4M |
| 净利润 | — | $-21.5M |
| 毛利率 | — | 37.9% |
| 营业利润率 | -86.7% | -135.9% |
| 净利率 | — | -173.9% |
| 营收同比 | -57.9% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-4.54 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTEU
| Q4 25 | $13.5M | $12.4M | ||
| Q3 25 | $49.5M | $8.9M | ||
| Q2 25 | $29.2M | $3.7M | ||
| Q1 25 | $26.5M | $18.2M | ||
| Q4 24 | $32.2M | — | ||
| Q3 24 | $29.2M | — | ||
| Q2 24 | $31.1M | — | ||
| Q1 24 | $32.4M | — |
净利润ASRTEU
| Q4 25 | — | $-21.5M | ||
| Q3 25 | $11.4M | $-4.8M | ||
| Q2 25 | $-16.4M | $-6.3M | ||
| Q1 25 | $-13.5M | $-24.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.9M | — | ||
| Q2 24 | $-3.7M | — | ||
| Q1 24 | $-4.5M | — |
毛利率ASRTEU
| Q4 25 | — | 37.9% | ||
| Q3 25 | — | 43.8% | ||
| Q2 25 | — | 30.8% | ||
| Q1 25 | — | -0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASRTEU
| Q4 25 | -86.7% | -135.9% | ||
| Q3 25 | 23.2% | -158.2% | ||
| Q2 25 | -27.5% | -526.1% | ||
| Q1 25 | -50.0% | -85.7% | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -11.6% | — | ||
| Q1 24 | -13.4% | — |
净利率ASRTEU
| Q4 25 | — | -173.9% | ||
| Q3 25 | 23.1% | -53.7% | ||
| Q2 25 | -56.0% | -172.7% | ||
| Q1 25 | -51.1% | -132.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.0% | — | ||
| Q2 24 | -11.8% | — | ||
| Q1 24 | -13.9% | — |
每股收益（稀释后）ASRTEU
| Q4 25 | $-4.54 | $-0.11 | ||
| Q3 25 | $0.11 | $-0.03 | ||
| Q2 25 | $-0.17 | $-0.03 | ||
| Q1 25 | $-0.14 | $-0.13 | ||
| Q4 24 | $-3.28 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $52.4M |
| 总债务越低越好 | — | $110.0M |
| 股东权益账面价值 | $94.0M | $229.2M |
| 总资产 | $267.0M | $430.4M |
| 负债/权益比越低杠杆越低 | — | 0.48× |
8季度趋势，按日历期对齐
现金及短期投资ASRTEU
| Q4 25 | $63.4M | $52.4M | ||
| Q3 25 | $93.4M | $91.9M | ||
| Q2 25 | $98.2M | $26.9M | ||
| Q1 25 | $87.3M | $29.7M | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTEU
| Q4 25 | — | $110.0M | ||
| Q3 25 | — | $109.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTEU
| Q4 25 | $94.0M | $229.2M | ||
| Q3 25 | $105.8M | $248.6M | ||
| Q2 25 | $93.3M | $264.7M | ||
| Q1 25 | $108.5M | $267.9M | ||
| Q4 24 | $121.1M | — | ||
| Q3 24 | $130.5M | — | ||
| Q2 24 | $132.2M | — | ||
| Q1 24 | $134.5M | — |
总资产ASRTEU
| Q4 25 | $267.0M | $430.4M | ||
| Q3 25 | $319.8M | $441.9M | ||
| Q2 25 | $273.8M | $359.4M | ||
| Q1 25 | $286.4M | $362.6M | ||
| Q4 24 | $284.7M | — | ||
| Q3 24 | $276.0M | — | ||
| Q2 24 | $279.4M | — | ||
| Q1 24 | $282.0M | — |
负债/权益比ASRTEU
| Q4 25 | — | 0.48× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $12.9M |
| 自由现金流经营现金流 - 资本支出 | — | $7.2M |
| 自由现金流率自由现金流/营收 | — | 57.8% |
| 资本支出强度资本支出/营收 | — | 46.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-45.0M |
8季度趋势，按日历期对齐
经营现金流ASRTEU
| Q4 25 | $-30.0M | $12.9M | ||
| Q3 25 | $-4.8M | $-20.3M | ||
| Q2 25 | $19.1M | $-9.9M | ||
| Q1 25 | $-12.5M | $-7.7M | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $-35.0K | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $7.5M | — |
自由现金流ASRTEU
| Q4 25 | — | $7.2M | ||
| Q3 25 | — | $-26.3M | ||
| Q2 25 | — | $-14.1M | ||
| Q1 25 | — | $-11.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ASRTEU
| Q4 25 | — | 57.8% | ||
| Q3 25 | — | -296.6% | ||
| Q2 25 | — | -385.2% | ||
| Q1 25 | — | -64.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ASRTEU
| Q4 25 | — | 46.7% | ||
| Q3 25 | — | 68.0% | ||
| Q2 25 | — | 115.1% | ||
| Q1 25 | — | 21.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ASRTEU
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
EU
暂无分部数据
